GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID | Title | Descriptor ▲ |
---|---|---|---|
8ANA | A0A7L6YWH1 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | C3SQU2 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | D8A1N0 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | D6IEK6 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | C3SR17 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | C3SFP2 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | A0A656YGQ7 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | C3SQZ2 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | P02413 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | A0A0H3EMH6 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | A0A1X3JBW6 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | A0A514EKV0 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | A0A370V6W8 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | A0A378BCJ4 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | A0A0E2L2H1 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | A0A0F6B7N1 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | D7Y3D8 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | S1E9P3 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | P68919 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | C3SSG7 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | C3SME2 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | P0A7M6 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | C3SR32 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8ANA | A0A657HW13 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
8BEV | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike (HexaPro variant) in complex with nanobody W25 (map 3, focus refinement on RBD, W25 and adjacent NTD) | |
8BEV | 8BEV | Cryo-EM structure of SARS-CoV-2 spike (HexaPro variant) in complex with nanobody W25 (map 3, focus refinement on RBD, W25 and adjacent NTD) | |
8BGG | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike (Omicron BA.1 variant) in complex with nanobody W25 (map 5, focus refinement on RBD, W25 and adjacent NTD) | |
8BGG | 8BGG | Cryo-EM structure of SARS-CoV-2 spike (Omicron BA.1 variant) in complex with nanobody W25 (map 5, focus refinement on RBD, W25 and adjacent NTD) | |
8A1F | Q15262 | Human PTPRK N-terminal domains MAM-Ig-FN1 | |
8AQW | P01863 | BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
8AQW | Q8R0I0 | BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
8AQW | P10104 | BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
8AQW | P0DTC2 | BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
7TU9 | O93430 | Alpha1/BetaB Heteromeric Glycine Receptor in Strychnine-Bound State | |
7TU9 | Q6DC22 | Alpha1/BetaB Heteromeric Glycine Receptor in Strychnine-Bound State | |
7TVI | O93430 | Alpha1/BetaB Heteromeric Glycine Receptor in Glycine-Bound State | |
7TVI | Q6DC22 | Alpha1/BetaB Heteromeric Glycine Receptor in Glycine-Bound State | |
7X93 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765 | |
7X93 | 7X93 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765 | |
7X94 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712 | |
7X94 | 7X94 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712 | |
7X95 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab709 | |
7X95 | 7X95 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab709 | |
7X96 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab847 | |
7X96 | 7X96 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab847 | |
7Z3R | P41160 | Crystal structure of the mouse leptin:LepR-IgCRH2 complex to 2.95 A resolution. | |
7Z3R | P48356 | Crystal structure of the mouse leptin:LepR-IgCRH2 complex to 2.95 A resolution. | |
7Z6T | A1C4M2 | Aspergillus clavatus M36 protease without the propeptide | |
8BBO | Q6GMX6 | SARS-CoV-2 Delta-RBD complexed with BA.2-36 Fab | |
8BBO | P0DOX7 | SARS-CoV-2 Delta-RBD complexed with BA.2-36 Fab |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024